{"id":58731,"date":"2024-02-28T05:25:22","date_gmt":"2024-02-28T05:25:22","guid":{"rendered":"https:\/\/medsname.com\/endace\/"},"modified":"2026-04-30T10:24:09","modified_gmt":"2026-04-30T10:24:09","slug":"endace","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ro\/product\/endace\/","title":{"rendered":"Endace"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">\u26a1 R\u0103spuns rapid \u2014 Ce este Endace?<\/h3>\n<p style=\"margin:0;\"><strong>Endace<\/strong> este un comprimat oral de la Cipla care con\u021bine <strong>acetat de megestrol<\/strong> la <strong>40 mg \u0219i 160 mg<\/strong> \u2014 un progestin sintetic utilizat ca <strong>stimulent al poftei de m\u00e2ncare<\/strong> \u00een cachexia canceroas\u0103 \u0219i anorexie asociat\u0103 HIV, \u0219i ca terapie endocrin\u0103 paliativ\u0103 \u00een cancerul de s\u00e2n avansat pozitiv pentru receptori hormonali \u0219i cancerul endometrial. Doz\u0103 standard de stimulare a poftei de m\u00e2ncare: <strong>400\u2013800 mg\/zi<\/strong> (de obicei 800 mg\/zi \u00een cachexia canceroas\u0103). \u00cenceperea \u00eembun\u0103t\u0103\u021birii poftei de m\u00e2ncare la 1\u20132 s\u0103pt\u0103m\u00e2ni; cre\u0219terea \u00een greutate (\u00een principal gr\u0103sime, nu mu\u0219chi) la 4\u20136 s\u0103pt\u0103m\u00e2ni. <strong>Risc crescut de tromboembolism venos<\/strong> \u2014 precau\u021bie la pacien\u021bii oncologici imobiliza\u021bi; lua\u021bi \u00een considerare profilaxia TVP. Alte avertismente: suprresie adrenal\u0103 la utilizare prelungit\u0103 (efect mineralocorticoid), hiperglicemie, reten\u021bie de lichide.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Ce beneficii ofer\u0103 MedsBase:<\/strong> Produc\u0103tor certificat WHO-GMP \u00b7 Ambalaj discret \u00b7 Livrare la nivel mondial \u00b7 Peste 1.400 de recenzii verificate <a href=\"https:\/\/medsbase.com\/ro\/reviews\/\">ale clien\u021bilor<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Fiecare comand\u0103 este acoperit\u0103 de politica noastr\u0103 de <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\"><strong>Politica noastr\u0103 de Reexpediere Garantat\u0103<\/strong><\/a> \u2014 dac\u0103 coletul dumneavoastr\u0103 nu sose\u0219te \u00een 20 de zile lucr\u0103toare, \u00eel relivr\u0103m.<\/p>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:0 0 24px 0;border-radius:4px;font-size:14px;\"><strong>\u26a0 Supraveghere specializat\u0103 necesar\u0103.<\/strong> Medicamentele pentru cancer trebuie prescrise de un oncolog tratant, cu un diagnostic confirmat, stadializare ini\u021bial\u0103 \u0219i un plan de tratament definit. Nu \u00eencepe\u021bi, nu opri\u021bi, nu modifica\u021bi doza \u0219i nu utiliza\u021bi medicamente pentru cancer \u00een afara unui plan de \u00eengrijire condus de oncologie. Majoritatea medicamentelor pentru cancer necesit\u0103 monitorizare regulat\u0103 prin analize de s\u00e2nge (hemoleucogram\u0103, teste hepatice, func\u021bie renal\u0103), sunt absolut contraindicate \u00een sarcin\u0103 \u0219i au interac\u021biuni medicamentoase semnificative.<\/div>\n<div style=\"background:#f4f8fb;border:1px solid #d6e4ec;padding:12px 18px;margin:14px 0;border-radius:4px;font-size:14px;color:#3a5160;text-align:center;\">\n<strong>\ud83d\udd12 Checkout criptat<\/strong> \u00b7 <strong>\ud83d\udcb3 Procesor verificat<\/strong> \u00b7 <strong>\ud83d\ude9a Livrare worldwide<\/strong> \u00b7 <strong>\u2b50 4,9\/5 de la peste 1.400 de clien\u021bi<\/strong>\n<\/div>\n<h2 class=\"wp-block-heading\">Ce este Endace?<\/h2>\n<p>Endace este un comprimat oral de la Cipla care con\u021bine <strong>acetat de megestrol<\/strong> (40 mg \u0219i 160 mg). Megestrolul este un progestin sintetic cu efecte puternice de stimulare a apetitului. Utilizarea predominant\u0103 modern\u0103 este ca terapie de suport pentru <strong>ca\u0219exia canceroas\u0103<\/strong> \u2014 pierderea involuntar\u0103 de greutate care afecteaz\u0103 majoritatea pacien\u021bilor cu cancer avansat \u0219i \u00eenr\u0103ut\u0103\u021be\u0219te semnificativ calitatea vie\u021bii \u0219i toleran\u021ba la tratament. De asemenea, p\u0103streaz\u0103 un rol de ni\u0219\u0103 \u00een terapia endocrin\u0103 paliativ\u0103 pentru cancerul avansat de s\u00e2n \u0219i endometrial pozitiv la receptori hormonali.<\/p>\n<h2 class=\"wp-block-heading\">Utiliz\u0103ri \u0219i indica\u021bii<\/h2>\n<ul>\n<li><strong>Ca\u0219exia canceroas\u0103<\/strong> \u2014 stimularea apetitului \u0219i cre\u0219terea \u00een greutate<\/li>\n<li><strong>Anorexie \u0219i pierdere \u00een greutate asociate HIV<\/strong> (mai pu\u021bin utilizat \u00een 2026 cu ART modern)<\/li>\n<li><strong>Terapie endocrin\u0103 paliativ\u0103 \u00een cancerul avansat de s\u00e2n HR+<\/strong> \u2014 linie ulterioar\u0103 dup\u0103 AI \u0219i tamoxifen<\/li>\n<li><strong>Cancer endometrial avansat<\/strong> paliere<\/li>\n<li><strong>Off-label:<\/strong> v\u0103p\u0103i de c\u0103ldur\u0103 la pacien\u021bii care nu pot utiliza HRT<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Doza \u0219i mod de administrare<\/h2>\n<ul>\n<li><strong>Ca\u0219exie canceroas\u0103 \/ Anorexie HIV:<\/strong> 400\u2013800 mg\/zi (adesea 800 mg\/zi) sub form\u0103 de suspensie sau echivalent tablet\u0103<\/li>\n<li><strong>Paliere \u00een cancerul de s\u00e2n:<\/strong> 160 mg\/zi \u00een doze divizate<\/li>\n<li><strong>Paliere \u00een cancerul endometrial:<\/strong> 80\u2013320 mg\/zi \u00een doze divizate<\/li>\n<\/ul>\n<ol>\n<li>Administra\u021bi cu alimente pentru a \u00eembun\u0103t\u0103\u021bi absorb\u021bia \u0219i a reduce grea\u021ba.<\/li>\n<li>O dat\u0103 pe zi sau \u00een doze divizate, \u00een func\u021bie de indica\u021bie.<\/li>\n<li><strong>Monitorizare obligatorie:<\/strong> greutate ini\u021bial\u0103, glicemie (megestrolul ridic\u0103 frecvent glicemia); TA; semne de TVP; simptome de suprresie adrenal\u0103. Hemoleucogram\u0103 periodic\u0103.<\/li>\n<li>Pentru ca\u0219exie, se a\u0219teapt\u0103 \u00eembun\u0103t\u0103\u021birea apetitului la 1\u20132 s\u0103pt\u0103m\u00e2ni \u0219i cre\u0219terea \u00een greutate la 4\u20136 s\u0103pt\u0103m\u00e2ni. Majoritatea c\u00e2\u0219tigului de greutate este sub form\u0103 de gr\u0103sime (nu mu\u0219chi), iar ad\u0103ugarea suportului nutri\u021bional \u0219i a exerci\u021biilor de rezisten\u021b\u0103, acolo unde este posibil, amplific\u0103 beneficiile.<\/li>\n<li><strong>Nu \u00eentrerupe\u021bi brusc<\/strong> dup\u0103 utilizare prelungit\u0103 \u2014 risc de criz\u0103 adrenal\u0103 datorit\u0103 suprresiei adrenale mediate de progestin. Reduce\u021bi progresiv sub \u00eendrumare specializat\u0103.<\/li>\n<\/ol>\n<h2 class=\"wp-block-heading\">Efecte Secundare<\/h2>\n<p><strong>Frecvente:<\/strong> cre\u0219tere \u00een greutate (efectul dorit \u00een cachexie), cre\u0219tere a apetitului, reten\u021bie de lichide, hiperglicemie, s\u00e2nger\u0103ri vaginale break-through, modific\u0103ri de stare, insomnie, transpira\u021bie, frisoane (paradoxal, la unii pacien\u021bi).<\/p>\n<p><strong>Important:<\/strong><\/p>\n<ul>\n<li><strong>Tromboembolism venos (TVP, EP)<\/strong> \u2014 lua\u021bi \u00een considerare anticoagularea profilactic\u0103 la pacien\u021bii cu cancer imobiliza\u021bi<\/li>\n<li>Suprresie adrenal\u0103 la utilizare prelungit\u0103 \u00een doze mari<\/li>\n<li>Diabet de nou-apari\u021bie sau agravare a controlului glicemic<\/li>\n<li>Hipertensiune arterial\u0103<\/li>\n<li>Tr\u0103s\u0103turi cushingoide la doze mari<\/li>\n<li>Neregularit\u0103\u021bi menstruale<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Avertismente<\/h2>\n<ul>\n<li><strong>Sarcina:<\/strong> contraindicate. Contraceptie fiabil\u0103 pe tot parcursul tratamentului.<\/li>\n<li><strong>Al\u0103ptarea:<\/strong> evita\u021bi.<\/li>\n<li><strong>TVP activ\u0103 sau tromboz\u0103 recent\u0103:<\/strong> evita\u021bi; alternativele includ corticosteroizi pentru cachexie (pe termen scurt) sau omega-3.<\/li>\n<li><strong>Diabet:<\/strong> monitoriza\u021bi cu aten\u021bie glicemia; este probabil\u0103 ajustarea dozei de insulin\u0103 sau a hipoglicemiante.<\/li>\n<li><strong>Insuficien\u021b\u0103 adrenal\u0103:<\/strong> reduce\u021bi progresiv, nu \u00eentrerupe\u021bi brusc dup\u0103 utilizare prelungit\u0103.<\/li>\n<li><strong>Factori de risc cardiovascular:<\/strong> precau\u021bie \u2014 reten\u021bie de lichide, hipertensiune.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Interac\u021biuni medicamentoase<\/h2>\n<table style=\"border-collapse:collapse;width:100%;margin:12px 0;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:10px;border:1px solid #ddd;\">Combina\u021bi cu<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;\">Efect<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;\">Ce s\u0103 face\u021bi<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Insulin\u0103 sau hipoglicemiante orale<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Megestrolul cre\u0219te glicemia \u2014 control redus<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Monitoriza\u021bi glicemia; ajusta\u021bi medicamentele antidiabetice.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Warfarin<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Posibil\u0103 modificare a INR<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Monitoriza\u021bi INR.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Alte progestine, estrogeni<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Progestine suprapuse \/ efecte Trombembolism venos (TEV)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Evita\u021bi combina\u021bia.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Inhibitori de aromataz\u0103<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Megestrolul furnizeaz\u0103 progestin exogen \u2014 rar utilizat \u00eempreun\u0103; administra\u021bi secven\u021bial<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Decizie specialist.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2 class=\"wp-block-heading\">Depozitare<\/h2>\n<ul>\n<li>Temperatur\u0103 ambient\u0103, 15\u201325\u00b0C, \u00een blisterul original.<\/li>\n<li>Depozita\u021bi \u00een afara reachii copiilor \u0219i animalelor de companie.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Alternative conexe pe MedsBase<\/h2>\n<p>Alte medicamente oncologice disponibile \u00eempreun\u0103 cu acest produs:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/endoxan\/\"><strong>Endoxan (ciclosfosfamid\u0103 50 mg)<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/celkeran\/\"><strong>Celkeran (clorambucil 2 \/ 5 mg)<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/temotero\/\"><strong>Temotero (temozolomid\u0103 20\/100 mg)<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/temozol-20\/\"><strong>Temozol (temozolomid\u0103 20 mg)<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/lomoother\/\"><strong>Lomoother (lomustin\u0103 40 mg)<\/strong><\/a><\/li>\n<\/ul>\n<p><a href=\"https:\/\/medsbase.com\/ro\/anti-cancer-medication\/\">R\u0103sfoi\u021bi toate medicamentele anti-cancer \u2192<\/a><\/p>\n<h2 id=\"faqs\">\u00centreb\u0103ri frecvente<\/h2>\n<h3 class=\"wp-block-heading\">C\u00e2nd voi observa efectul stimulent al apetitului?<\/h3>\n<p>Cre\u0219terea apetitului \u00eencepe de obicei la <strong>1\u20132 s\u0103pt\u0103m\u00e2ni<\/strong>. Cre\u0219terea m\u0103surabil\u0103 \u00een greutate (\u00een principal gr\u0103sime, cu o component\u0103 mai mic\u0103 de lichide) la <strong>4\u20136 s\u0103pt\u0103m\u00e2ni<\/strong>. Majoritatea cre\u0219terii \u00een greutate este gr\u0103sime \u2014 megestrolul nu cre\u0219te semnificativ masa muscular\u0103. Ad\u0103ugarea de suport nutri\u021bional \u0219i exerci\u021bii de rezisten\u021b\u0103 u\u0219oar\u0103, acolo unde este posibil, amplific\u0103 beneficiul.<\/p>\n<h3 class=\"wp-block-heading\">De ce reprezint\u0103 tromboembolismul venos un risc?<\/h3>\n<p>Megestrolul este un progestin \u0219i prezint\u0103 acela\u0219i risc de TEB ca toate contraceptivele hormonale \u0219i progestinele, \u00een special la pacien\u021bii cu cancer (care au deja un risc de baz\u0103 de TEB de 5\u201310 ori mai mare). Fi\u021bi aten\u021bi la umfl\u0103turi unilaterale la picior, dureri bruste \u00een piept sau dificult\u0103\u021bi de respira\u021bie; solicita\u021bi \u00eengrijiri medicale \u00een aceea\u0219i zi dac\u0103 apar aceste simptome. Lua\u021bi \u00een considerare anticoagularea profilactic\u0103 la pacien\u021bii cu cancer imobiliza\u021bi care iau megestrol.<\/p>\n<h3 class=\"wp-block-heading\">Endace va cre\u0219te nivelul zah\u0103rului din s\u00e2nge?<\/h3>\n<p>Da \u2014 frecvent. Megestrolul mimeaz\u0103 unele dintre efectele metabolice ale corticosteroidelor (perturb\u0103 ac\u021biunea insulinei, cre\u0219te produc\u021bia hepatic\u0103 de glucoz\u0103). Pacien\u021bii diabetici au de obicei nevoie de ajustarea \u00een sus a medicamentelor hipoglicemiante; diabetul de debut poate ap\u0103rea la pacien\u021bii nediabatici care iau megestrol \u00een doze mari pe termen lung. Monitoriza\u021bi glicemia capilar\u0103 s\u0103pt\u0103m\u00e2nal la \u00eenceput.<\/p>\n<h3 class=\"wp-block-heading\">De ce trebuie s\u0103 reduc treptat doza de Endace \u0219i nu s\u0103 o \u00eentrerup brusc?<\/h3>\n<p>Administrarea pe termen lung a dozelor mari de megestrol suprima axa adrenal\u0103 (efect mineralocorticoid asupra axei hipotalamo-hipofizo-adrenale). \u00centreruperea brusc\u0103 dup\u0103 &gt; 4\u20136 s\u0103pt\u0103m\u00e2ni de utilizare \u00een doze mari poate duce la <strong>criz\u0103 adrenal\u0103<\/strong> \u2014 grea\u021b\u0103, v\u0103rs\u0103turi, hipotensiune, hipoglicemie. Reduce\u021bi doza treptat pe o perioad\u0103 de 2\u20134 s\u0103pt\u0103m\u00e2ni sub supraveghere specializat\u0103.<\/p>\n<h3 class=\"wp-block-heading\">Exist\u0103 alternative la Endace pentru cachexia canceroas\u0103?<\/h3>\n<p>Op\u021biuni limitate cu dovezi solide. <strong>Corticoesteroizi<\/strong> (dexametazon\u0103 4 mg\/zi) stimuleaz\u0103 pe termen scurt apetitul, dar prezint\u0103 toxicitate sever\u0103 pe termen lung. <strong>Canabinoide<\/strong> (dronabinol acolo unde este legal) au dovezi modeste. <strong>Anamorelin<\/strong> (agonist de ghrelin\u0103) este aprobat \u00een Japonia \u0219i \u00een alte pie\u021be. <strong>Olanzapine<\/strong> dozele mici au dovezi emergente de sus\u021binere. <strong>Interven\u021bii nutri\u021bionale \u0219i de exerci\u021biu<\/strong> r\u0103m\u00e2n linia de prim\u0103 inten\u021bie. Discuta\u021bi cu echipa de \u00eengrijiri paliative.<\/p>\n<h3 class=\"wp-block-heading\">Poate Endace s\u0103 trateze cancerul meu de s\u00e2n?<\/h3>\n<p>Megestrolul are un rol de ni\u0219\u0103 \u00een terapia endocrin\u0103 paliativ\u0103 pentru cancerul de s\u00e2n HR+ avansat \u2014 de obicei <strong>dup\u0103 e\u0219ecul inhibitorului de aromataz\u0103 \u0219i tamoxifen<\/strong>. Nu mai este o alegere de prim\u0103 sau a doua linie endocrin\u0103 \u00een majoritatea practicilor moderne; inhibitorii CDK4\/6 + AI \/ fulvestrant l-au \u00eenlocuit \u00een mare m\u0103sur\u0103. Decizie de oncologie specializat\u0103.<\/p>\n<h3 class=\"wp-block-heading\">Este Endace sigur \u00een sarcin\u0103?<\/h3>\n<p>Nu \u2014 contraindicated. Megestrolul este un progestin \u0219i poate provoca masculinizare fetal\u0103 \u0219i alte efecte de dezvoltare. Contraceptie fiabil\u0103 pe tot parcursul tratamentului.<\/p>\n<h3 class=\"wp-block-heading\">Pot s\u0103 consum alcool \u00een timpul tratamentului cu Endace?<\/h3>\n<p>Cantit\u0103\u021bi mici ocazionale sunt tolerabile, dar consumul excesiv de alcool agraveaz\u0103 efectele secundare metabolice (hiperglicemie, hipertensiune, reten\u021bie de lichide). Discuta\u021bi cu echipa de \u00eengrijire de sprijin \u00een contextul \u00eengrijirii oncologice generale.<\/p>\n<p><!-- medsbase-why-order --><\/p>\n<h3>De ce s\u0103 comanzi de la MedsBase<\/h3>\n<p>Fiecare lot este procurat de la un <strong>produc\u0103tor certificat WHO-GMP<\/strong>. Comenzile sunt expediate \u00een ambalaje simple, f\u0103r\u0103 marc\u0103, de la partenerii no\u0219tri de onorare \u0219i acoperite de <a href=\"\/ro\/medsbase-re-shipment-assurance-policy\/\">Politica noastr\u0103 de Reexpediere Garantat\u0103<\/a>: dac\u0103 un colet nu ajunge \u00een 20 de zile lucr\u0103toare, trimitem gratuit o nou\u0103 comand\u0103, f\u0103r\u0103 \u00eentreb\u0103ri.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Medicamente Anticanceroase Asem\u0103n\u0103toare<\/h3>\n<p>Alte medicamente oncologice disponibile \u00eempreun\u0103 cu acest produs:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/cytomid\/\">Cytomid (flutamid\u0103 250 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/bicalumutide\/\">Bicalumutid\u0103 (bicalutamid\u0103 50 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/bdenza\/\">Bdenza (enzalutamid\u0103 40 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/tamilong\/\">Tamilong (tamoxifen 10\/20 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/xtane\/\">Xtane (exemestan 25 mg)<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 Combatere pierderea poftei de m\u00e2ncare<br \/>\n\u2705 Trateaz\u0103 cancerul de s\u00e2n<br \/>\n\u2705 Controlul cancerului endometrial<br \/>\n\u2705 Ajut\u0103 la cre\u0219terea \u00een greutate<br \/>\n\u2705 \u00cembun\u0103t\u0103\u021be\u0219te calitatea vie\u021bii<\/p>\n<p>Endace con\u021bine acetat de megestrol.<\/p>","protected":false},"featured_media":58732,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3595,3141,3223],"product_tag":[4556,4557],"class_list":{"0":"post-58731","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-anti-cancer-medication","7":"product_cat-category-overview","8":"product_cat-chronic-conditions","9":"product_tag-endace","10":"product_tag-megestrol","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product\/58731","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/comments?post=58731"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media\/58732"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media?parent=58731"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_brand?post=58731"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat?post=58731"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_tag?post=58731"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}